(a) The Department shall review the PDMD information monthly, including a review to identify information that appears to indicate whether a patient is obtaining prescriptions in a manner that may represent misuse or abuse of controlled substances, based on prescribing criteria determined by the Commissioner upon consultation with the Committee. The prescribing criteria must be posted on the website of the Department and be available in print upon request.
(b) (1) If the PDMD information appears to indicate misuse or abuse may have occurred, the Department shall notify the prescribers and dispensers who have prescribed or dispensed the prescriptions and provide three consecutive monthly reports to the prescribers and dispensers.(2) If after three months of providing reports to the prescribers and dispensers, the information continues to suggest that misuse or abuse may be occurring, the Department shall send a report to the licensing boards.(3) If misuse or abuse is identified, the Department shall notify the practitioners and dispensers who prescribed or dispensed the prescriptions and the United States Diversion Control Division of the United States Drug Enforcement Administration.
(1) If the PDMD information appears to indicate misuse or abuse may have occurred, the Department shall notify the prescribers and dispensers who have prescribed or dispensed the prescriptions and provide three consecutive monthly reports to the prescribers and dispensers.
(2) If after three months of providing reports to the prescribers and dispensers, the information continues to suggest that misuse or abuse may be occurring, the Department shall send a report to the licensing boards.
(3) If misuse or abuse is identified, the Department shall notify the practitioners and dispensers who prescribed or dispensed the prescriptions and the United States Diversion Control Division of the United States Drug Enforcement Administration.